This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Rheumatoid Arthritis
and you are
between 18 and 99
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a randomized, double-blind study comparing ABT-494 monotherapy to Methotrexate (MTX) monotherapy in MTX-naïve subjects with moderately to severely active rheumatoid arthritis.

Provided treatments

  • Drug: Upadacitinib Placebo
  • Drug: Methotrexate
  • Drug: Methotrexate Placebo
  • Drug: Upadacitinib

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02706873. The sponsor of the trial is AbbVie and it is looking for 1002 volunteers for the current phase.
Official trial title:
A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) Once Daily Monotherapy to Methotrexate (MTX) Monotherapy in MTX-Naïve Subjects With Moderately to Severely Active Rheumatoid Arthritis